Price of SYRE with the Market Cap of PCVX

If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00. The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B).

Result

With The Market Cap of

$115.16
(1.06x)

SYRE is 0.95x under PCVX

SYRE.US Market Cap
SYRE.US M. Cap:
$10,059,762,600
PCVX.US Market Cap
PCVX.US M. Cap:
$10,628,524,010
Wonder your profit?
Estimated value:
$0.00
SYRE
SYRE is 0.95x under PCVX
SYRE.US Market Cap
SYRE.US M. Cap:
$10,059,762,600
PCVX.US Market Cap
PCVX.US M. Cap:
$10,628,524,010

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Spyre Therapeutics, Inc. vs Vaxcyte, Inc.: key figures

Spyre Therapeutics, Inc. SYRE Vaxcyte, Inc. PCVX
Rank #2017 #1939
Price $109.00 $67.53
Market cap $10.06B $10.63B
Shares Outstanding 92.29M 157.39M
Change (1 day) +4.95% +5.70%
Change (1 year) +381.66% +48.25%

The other way round: PCVX with the market cap of SYRE

$63.92 (0.95x)

If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.

Price of PCVX with the Market Cap of SYRE

Price of SYRE with the Market Cap of PCVX: the last 12 months

The price of one SYRE if Spyre Therapeutics, Inc. had the market cap of Vaxcyte, Inc., at the end of each month. Highest: $115.16 (Nov 2026). Lowest: $20.72 (May 2026).

  1. $83.87 Dec 2025
  2. $97.38 Jan 2026
  3. $24.28 Feb 2026
  4. $22.85 Mar 2026
  5. $22.51 Apr 2026
  6. $20.72 May 2026
  7. $23.43 Jun 2026
  8. $90.42 Jul 2026
  9. $101.00 Aug 2026
  10. $94.61 Sep 2026
  11. $105.78 Oct 2026
  12. $115.16 Nov 2026

Questions about Spyre Therapeutics, Inc. and Vaxcyte, Inc.

What would the price of Spyre Therapeutics, Inc. be with the market cap of Vaxcyte, Inc.?

If Spyre Therapeutics, Inc. (SYRE) had the market cap of Vaxcyte, Inc. (PCVX), one SYRE would cost $115.16, 1.06 times today's price of $109.00.

How much bigger is Vaxcyte, Inc. than Spyre Therapeutics, Inc.?

The market cap of Vaxcyte, Inc. ($10.63B) is 1.06 times that of Spyre Therapeutics, Inc. ($10.06B). In Dec 2025 the gap was 2.56 times.

What would the price of Vaxcyte, Inc. be with the market cap of Spyre Therapeutics, Inc.?

If Vaxcyte, Inc. (PCVX) had the market cap of Spyre Therapeutics, Inc. (SYRE), one PCVX would cost $63.92, 5.35% less than today's price of $67.53.

How is this price calculated?

The market cap of Vaxcyte, Inc. ($10.63B) is divided by the number of SYRE in circulation (92.29M). Market cap is the price multiplied by the number of coins or shares in circulation.